Status:

COMPLETED

Pulpotomy Medications in Primary Teeth

Lead Sponsor:

Suez Canal University

Conditions:

Drug Effect

Eligibility:

All Genders

7-9 years

Phase:

NA

Brief Summary

this study is aimed to evaluate and compare the pulp response to ACTIVA BioACTIVE Base/Liner and MTA as pulpotomy medication in primary teeth.

Detailed Description

Pulpotomy is an endodontic technique that involves amputating the coronal pulp and covering the residual root pulp with a clinically effective pulp medicament that is bactericidal, capable of forming ...

Eligibility Criteria

Inclusion

  • Healthy \& cooperative child
  • No history of spontaneous pain
  • No pathologic tooth mobility
  • Normal gingival and periodontal condition
  • Absence of furcal/periapical radiolucency

Exclusion

  • Uncooperativeness of child and/or parents
  • Unrestorable tooth
  • history of spontaneous pain
  • Percussion sensitivity

Key Trial Info

Start Date :

October 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 5 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05300152

Start Date

October 2 2022

End Date

August 5 2024

Last Update

November 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Suez Canal University

Ismailia, Egypt